版權(quán)說(shuō)明：本文檔由用戶(hù)提供并上傳，收益歸屬內(nèi)容提供方，若內(nèi)容存在侵權(quán)，請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
BackgroundCRC:majorcauseofdeathanddiseaseBackgroundProcessesofcolorectalcarcinogenesislendthemselvestoscreeningBackgroundAsubstantialproportionnevertested!ScreeningforCRCiscost-effectiveAsimple,noninvasivetestmightimproveclinicalout-comes28%BackgroundColorectalcancerarisesfromaccumulatedgeneticandepigeneticalterationsAimEvaluatethemultitargetstoolDNAtestasatoolforscreeningAimPrimaryaim:DNAtestinthedetectionofCRCSecondaryaims:DNAtestinthedetectionofadvancedprecancerouslesionsandtocompareitwithacommerciallyavailablefecalimmunochemicaltest(FIT)DNAtestVSMethodsStudyPopulation:2011.6-2012.1190sites
AsymptomaticpersonsAgesof50to84ataverageriskforCRCScheduledtoundergoscreeningcolonoscopySecondaryaims:DNAtestinthedetectionofadvancedprecancerouslesionsandtocompareitwithacommerciallyavailablefecalimmunochemicaltest(FIT)Asimple,noninvasivetestmightimproveclinicalout-comesAsubstantialproportionnevertested!digestivecancer,orinflammatoryboweldiseasepreviouscolonoscopy,bariumenema,CT,sigmoidoscopyundergonecolorectalresectionAdvancedprecancerouslesions:Advancedadenomashigh-gradedysplasiafamilyhistorySessileserratedpolypsmeasuring1cmormoreindiameterundergonecolorectalresectionStudyPopulation:Agesof50to84ataverageriskforCRCpreviouscolonoscopy,bariumenema,CT,sigmoidoscopyConclusionsSessileserratedpolypsmeasuring1cmormoreindiameterCRC,stagedeterminedwiththeuseoftheAJCCstagingsystempositiveresultsonfecalbloodtesting,rectalbleedingSecondaryaims:DNAtestinthedetectionofadvancedprecancerouslesionsandtocompareitwithacommerciallyavailablefecalimmunochemicaltest(FIT)CRC,stagedeterminedwiththeuseoftheAJCCstagingsystemMethodsExcluded
personalhistory:colorectalneoplasia,digestivecancer,orinflammatoryboweldisease
previouscolonoscopy,bariumenema,CT,sigmoidoscopy
positiveresultsonfecalbloodtesting,rectalbleedingundergonecolorectalresectionfamilyhistoryMethodsPrimaryandSecondaryOutcomesCRC,stagedeterminedwiththeuseoftheAJCCstagingsystem
Advancedprecancerouslesions:
Advancedadenomashigh-gradedysplasiawith≥25%villoushistologicfeaturesmeasure≥1cminthegreatestdimension
Sessileserratedpolypsmeasuring1cmormoreindiameteraberrantlymethylatedBMP3andNDRG4promoterregionsmutantKRASimmunochemicalassayforhumanhemoglobinFITMultitargetstoolDNAtestResults127760.7%7.6%ResultsResultsResultsFigure3.ReceiverOperatingCharacteristic(ROC)CurvesComparingDNATestingandFITfortheDetectionofColorectalCancerandAdvancedColorectalNeoplasia.ResultsMultitargetDNAtestingdetectedclinicallysignificantlesionsmoreefficientlythanFIT.ConclusionsAstooltestcombiningalteredhumanDNAandfecalhemoglobinshowedhighersensitivitythanacommercialFITforbothCRCandadvancedprecancerouslesions,althoughwithlowerspecificity.TranslationalResearchAug.12,2014FDAApprovesCologuardFirstandOnlyStoolDNANoninvasiveColorectalCancerScreeningTestReceivedaproposedcove-ragememorandumfromtheCentersforMedicareandMedicaidServices(CMS)ProcessesofcolorectalcarcinogenesislendthemselvestoscreeningAdvancedprecancerouslesions:CRC,stagedeterminedwiththeuseoftheAJCCstagingsystem1190sitesundergonecolorectalresectionAdvancedprecancerouslesions:familyhistoryAstooltestcombiningalteredhumanDNAandfecalhemoglobinshowedhighersensitivitythanacommercialFITforbothCRCandadvancedprecancerouslesions,althoughwithlowerspecificity.positiveresultsonfecalbloodtesting,rectalbleedingpositiveresultsonfecalbloodtesting,rectalbleedingMultitargetstoolDNAtestMultitargetDNAtestingdetectedclinicallysignificantlesionsmoreefficientlythanFIT.Aneasy-to-usescreen-ingtestEvaluatethemultitargetstoolDNAtestasatoolforscreeningColorectalcancerarisesfromaccumulatedgeneticandepigeneticalterationsCRC,stagedeterminedwiththeuseoftheAJCCstagingsystempositiveresultsonfecalbloodtesting,rectalbleedingAsymptomaticpersonsAdvancedadenomashigh-gradedysplasiaColorectalcancerarisesfromaccumulatedgeneticandepigeneticalterationsStudyPopulation:PeopleataverageriskforcolorectalcancerAneasy-to-usescreen-ingtest599$BackgroundAsubstantialproportionnevertested!ScreeningforCRCiscost-effectiveAsimple,noninvasivetestmightimproveclinicalout-comes28%MethodsStudyPopulation:2011.6-2012.1190sites
AsymptomaticpersonsAgesof50to84ataverageriskforCRCScheduledtoundergoscreeningcolonoscopyMethodsPrimaryandSecondaryOutcomesCRC,stagedeterminedwiththeuseoftheAJCCstagingsystem
Advancedprecancerouslesions:
Advancedadenomashigh-gradedysplasiawith≥25%villoushistologicfeaturesmeasure≥1cminthegreatestdimension
Sessileserratedpolypsmeasuring1cmormoreindiameterResultsFigure3.ReceiverOperatingCharacteristic(ROC)CurvesComparingDNATestingandFITfortheDetectionofColorectalCancerandAdvancedColorectalNeoplasia.ConclusionsAstooltestcombiningalteredhumanDNAandfecalhemoglobinshowedhighersensitivitythanacommercialFITforbothCRCandadvancedprecancerouslesions,althoughwithlowerspecificity.1190sitesAstooltestcombiningalteredhumanDNAandfecalhemoglobinshowedhighersensitivitythanacommercialFITforbothCRCandadvancedprecancerouslesions,althoughwithlowerspecificity.CRC,stagedeterminedwiththeuseoftheAJCCstagingsystemAsymptomaticpersonspositiveresultsonfecalbloodtesting,rectalbleedingdigestivecancer,orinflammatoryboweldiseaseAgesof50to84ataverageriskforCRCpreviouscolonoscopy,bariumenema,CT,sigmoidoscopyPrimaryandSecondaryOutcomesmeasure≥1cminthegreatestdimensionAdvancedadenomashigh-gradedysplasiaSessileserratedpolypsmeasuring1cmormoreindiameterCRC,stagedeterminedwiththeuseoftheAJCCstagingsystemFDAApprovesCologuardSecondaryaims:DNAtestinthedetectionofadvancedprecancerouslesionsandtocompareitwithacommerciallyavailablefecalimmunochemicaltest(FIT)Asimple,noninvasivetestmightimproveclinicalout-comespositiveresultsonfecalbloodtesting,rectalbleedingpositiveresultsonfecalbloodtesting,rectalbleedingPrimaryandSecondaryOutcomesScheduledtoundergoscreeningcolonoscopyAdvancedprecancerouslesions:ReceiverOperatingCharacteristic(ROC)CurvesComparingDNATestingandFITfortheDetectionofColorectalCancerandAdvancedColorectalNeoplasia.undergonecolorectalresectionAdvancedadenomashigh-gradedysplasiaMultitargetDNAtestingdetectedclinicallysignificantlesionsmoreefficientlythanFIT.undergonecolorectalresectionAsubstantialproportionnevertested!CRC,stagedeterminedwiththeuseoftheAJCCstagingsystemFDAApprovesCologuardCRC,stagedeterminedwiththeuseoftheAJCCstagingsystemCRC,stagedeterminedwiththeuseoftheAJCCstagingsystemCRC,stagedeterminedwiththeuseoftheAJCCstagingsystemwith≥25%villoushistologicfeaturesCRC,stagedeterminedwiththeuseoftheAJCCstagingsystemFirstandOnlyStoolDNANoninvasiveColorectalCancerScreeningTestSecondaryaims:DNAtestinthedetectionofadvancedprecancerouslesionsandtocompareitwithacommerciallyavailablefecalimmunochemicaltest(FIT)Sessileserratedpolypsmeasuring1cmormoreindiameterConclusionsdigestivecancer,orinflammatoryboweldiseasepersonalhistory:colorectalneoplasia,Advancedprecancerouslesions:Colorectalcancerarisesfromaccumulatedgeneticandepigeneticalterationspreviouscolonoscopy,bariumenema,CT,sigmoidoscopyPrimaryaim:DNAtestinthedetectionofCRCEvaluatethemultitargetstoolDNAtestasatoolforscreeningCRC,stagedeterminedwiththeuseoftheAJCCstagingsystempreviouscolonoscopy,bariumenema,CT,sigmoidoscopyPrimaryandSecondaryOutcomesAsymptomaticpersonsMultitargetDNAtestingdetectedclinicallysignificantlesionsmoreefficientlythanFIT.positiveresultsonfecalbloodtesting,rectalbleedingMultitargetstoolDNAtestpositiveresultsonfecalbloodtesting,rectalbleedingAsymptomaticpersonsfamilyhistoryAsubstantialproportionnevertested!Advancedprecancerouslesions:Processesofcolorectalcarcinogenesislendthemselvestoscreeningpositiveresultsonfecalbloodtesting,rectalbleedingPrimaryandSecondaryOutcomesMultitargetDNAtestingdetectedclinicallysignificantlesionsmoreefficientlythanFIT.Advancedprecancerouslesions:Advancedprecancerouslesions:measure≥1cminthegreatestdimensionAdvanc
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明，都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等，如果需要附件，請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶(hù)所有。
- 3. 本站RAR壓縮包中若帶圖紙，網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽，若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間，僅對(duì)用戶(hù)上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理，對(duì)用戶(hù)上傳分享的文檔內(nèi)容本身不做任何修改或編輯，并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容，請(qǐng)與我們聯(lián)系，我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶(hù)因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 秘書(shū)工作中的自我提升方案計(jì)劃
- 美術(shù)可愛(ài)的動(dòng)物教學(xué)設(shè)計(jì)
- 探秘小宇宙幼兒園教學(xué)工作計(jì)劃文檔
- 家長(zhǎng)委員會(huì)活動(dòng)計(jì)劃
- 港口碼頭建設(shè)招標(biāo)合同三篇
- 專(zhuān)職安全管理人員考核題庫(kù)
- 體育營(yíng)銷(xiāo)健身俱樂(lè)部男女健身教練培訓(xùn)
- 惠寶自信源于我們的內(nèi)心
- 臨床藥師問(wèn)診技巧
- PMC工作計(jì)劃專(zhuān)題
- 醫(yī)學(xué)免疫學(xué)名詞解釋和簡(jiǎn)答題
- 自行車(chē)連鎖店運(yùn)營(yíng)手冊(cè)范本
- 銀行分行第一屆辯論賽方案
- 高中思想政治課《公司的經(jīng)營(yíng)與發(fā)展》教學(xué)案例分析
- 起重機(jī)械自檢報(bào)告(共5頁(yè))
- （精選）活動(dòng)房產(chǎn)品手冊(cè)Word版
- 淺析資產(chǎn)評(píng)估中稅收事項(xiàng)
- 武建〔2005〕273號(hào)
- IEEE1588學(xué)習(xí)筆記
- 危險(xiǎn)化學(xué)品企業(yè)安全風(fēng)險(xiǎn)智能化管控平臺(tái)建設(shè)指南（試行）
- 亞龍YL-335B實(shí)訓(xùn)項(xiàng)目書(shū)
評(píng)論
0/150
提交評(píng)論